Publications

Journal of Internal Medicine - Commentary

Assessing and regulating homeopathic products

Homeopathic products and practices

Assessing the evidence and ensuring consistency in regulating medical claims in the EU

Genome Editing: Scientific opportunities, public interests, and policy options in the EU

A new report by the European Academies' Science Advisory Council on genome editing gives advice to European…

Gain of Function: experimental applications relating to potentially pandemic pathogens

Background of this latest EASAC study is the debate about risks and benefits of research that modifies viruses to better…

New Breeding Techniques

In this statement we express our views on the critical importance of supporting innovation in plant breeding to…

Antimicrobial drug discovery: greater steps ahead

Infectious diseases account for a substantial proportion of deaths worldwide. Continuing progress in the treatment of…

Risks to Plant Health: European Union Priorities for tackling emerging Plant Pests and Diseases

The introduction and spread of pests and diseases among food crops and other plant species in forestry, horticulture and…

Planting the future: opportunities and challenges for using crop genetic improvement technologies for sustainable agriculture

Agriculture faces major challenges to deliver food security at a time of increasing pressures from climate change,…

Direct-to-consumer genetic testing for health-related purposes in the European Union: the view from EASAC and FEAM

Until recently, human genetic testing was mainly confined to specialist medical genetic services, traditionally focusing…

Plant Genetic Resources for Food and Agriculture

Agriculture in Europe faces some major challenges, associated with the need to deliver food security worldwide at a time…

Infectious Diseases and the Future: Policies for Europe

Summaries of the EASAC report: European Public Health and Innovation Policy for Infectious Disease: The View from EASAC …

Impact of Engineered Nanomaterials on Health: Considerations for Benefit-Risk Assessment

Nanotechnology and its importance for Europe Nanotechnology encompasses the design, characterisation, production and…

European Public Health and iInnovation Policy for Infectious Disease: the View from EASAC

There have been major advances during the past century in research into and treatment of infectious disease. However,…

The Lancet

Health benefits of policies to mitigate climate change

Realising European Potential in Synthetic Biology: Scientific Opportunities and Good Governance

Synthetic biology covers the design and construction of novel biological components, systems and processes "that are not…

Climate Change and Infectious Diseases in Europe

Climate exerts both direct and indirect effects on the appearance and spread of human and animal infectious diseases.…

Healthcare-associated Infections: the View from EASAC

Healthcare-associated infections are an increasing problem for the European Union. Many Member States are spending a…

Drug-resistant Tuberculosis

Worldwide, more than nine million people develop active tuberculosis (TB) every year, with 1.7 million dying from the…

Combating the Threat of Zoonotic Infections

Abstract: Most new human pathogens reported in the past 25 years, such as influenza and SARS, have zoonotic origins.…

The use of EU structural funds in science and technology

Abstract: EASAC issued a statement reiterating the role of science and technology in developing the economies of the…

Biosciences Publications